MRVI
Maravai Lifesciences Holdings Inc
7.20$
-3.0%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +41.8% | -8.0% | +87.3% | +11.9% | +50.7% | +46.9% | -6.0% | +11.5% | +6.9% | -0.6% | -21.2% | +7.0% | -61.4% | -12.8% | -3.0% | +10.9% | -13.4% | +14.4% | -11.2% | -13.5% | -16.9% | +1.2% | -12.2% | +19.8% | +32.0% | -21.9% | – | |
| – | -14.2% | +38.6% | -6.8% | +18.4% | +34.2% | +20.5% | -14.8% | +26.1% | -1.5% | -6.3% | +1.8% | +39.5% | -36.8% | +28.5% | -15.2% | -4.3% | +9.2% | -0.2% | -3.8% | +1.7% | +4.5% | +1.3% | -9.2% | +4.6% | -14.6% | -4.2% | – | |
| – | +96.8% | -28.0% | +164.9% | +10.1% | +55.8% | +54.1% | -4.1% | +8.8% | +8.8% | +0.5% | -25.4% | -1.1% | -70.1% | -43.5% | +17.7% | +29.3% | -33.8% | +35.9% | -19.2% | -33.2% | -59.3% | +0.6% | -27.2% | +116.5% | +175.3% | -38.7% | – | |
| – | +282.4% | -57.3% | +16.8% | +12.0% | +3.3% | -10.7% | +0.9% | +371.4% | -59.7% | +15.7% | +26.1% | -7.0% | -17.3% | +1.2% | +3.6% | +5.7% | +9.5% | +5.0% | -17.8% | +5.0% | +7.2% | -0.1% | +100.1% | -61.2% | +2.7% | -4.8% | – | |
| – | +2.2% | -0.9% | +28.3% | +359.5% | -75.3% | +3.6% | +4.6% | +1.6% | +29.8% | -39.0% | +52.0% | +20.8% | +3.9% | -8.5% | +9.9% | -1.0% | +6.3% | -0.8% | -3.6% | +5.5% | -4.1% | -2.5% | -8.2% | -10.8% | -7.9% | +10.2% | – | |
| – | -94.8% | +1,926.3% | +27.2% | +95.3% | -41.4% | +3.1% | -34.9% | +113.4% | +0.5% | -33.5% | +47.5% | +16.7% | +1.4% | -13.0% | +22.4% | +1.3% | -3.2% | -0.1% | +342.4% | -71.1% | -0.4% | +30.2% | -248.3% | – | +64.5% | +14.4% | – | |
| – | +2,607.3% | -76.7% | +463.1% | -31.7% | +191.9% | +68.4% | +1.2% | -2.8% | +10.8% | +8.0% | -35.3% | -6.5% | -97.7% | -558.5% | – | – | – | – | – | – | – | – | – | -105.8% | – | -709.9% | – | |
| – | -4.4% | +1.1% | -5.0% | +24.2% | -10.2% | -3.2% | +0.5% | -42.3% | -39.9% | +66.4% | -29.3% | +224.6% | +16.2% | -40.7% | +65.7% | +32.3% | -29.5% | +9.9% | +14.2% | -17.4% | -39.8% | +0.5% | +0.4% | -4.2% | -12.3% | -16.4% | – | |
| – | – | -97.5% | +5,611.1% | -61.6% | +500.9% | +63.6% | +3.5% | -4.8% | +16.0% | +4.9% | -35.0% | -15.7% | -104.7% | – | – | – | -103.4% | – | – | – | – | – | – | – | – | – | – | |
| – | – | -121.0% | – | – | +3,615.2% | -16.9% | +65.5% | -6.7% | +13.7% | -8.6% | -22.8% | -40.1% | -137.6% | – | – | – | -100.0% | -998.5% | – | -102.3% | – | -2,746.9% | – | – | -2,616.7% | – | – | |
| – | – | -99.1% | +18,716.4% | -66.3% | +76.0% | +112.7% | +9.8% | +2.7% | +20.6% | +6.5% | -37.6% | -15.4% | -100.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +424.4% | -64.9% | +258.7% | -43.6% | +249.6% | +58.4% | +1.8% | -9.0% | +17.8% | +5.4% | -32.7% | -8.5% | -84.3% | -70.0% | -23.6% | +16,316.5% | -99.7% | +332.9% | -1,648.0% | – | – | – | – | – | – | -129.4% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.